Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia
Clinical trial NCT01327014 · COMPLETED
Trial details
- NCT number
- NCT01327014
- Sponsor
- Beijing Peking University WBL Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.